CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Monthly Vitals: Your Advocacy Update
CHA Submits Comments in Response to Medicaid Provider Tax Proposed Rule
The Pharmacy That Keeps Brynn Dancing
Monthly Vitals: Your Advocacy Update
Learn about Children’s Hospital Association’s latest advocacy efforts and recent legislative impacts for children’s hospitals and health systems.
July 30, 2025
CHA Submits Comments in Response to Medicaid Provider Tax Proposed Rule
Provider taxes are important mechanisms used to fund programs and support providers that treat a large volume of Medicaid patients, including children’s hospitals.
July 15, 2025
The Pharmacy That Keeps Brynn Dancing
The Cincinnati Children’s home care pharmacy is indispensable to children with complex medical conditions.
July 10, 2025
